Unlocking the
health benefits of cannabinoids

Cannabis Knowledge

Press & Media Hub

Careers

Bild mit dem Management Team von Sanity Group. Von links nach rechts: Seyit Kaya, Annika Marie Rudolph, Finn Age Hänsel, Lodewijk Sutorius, Adrian Frenzel

What we do

Sanity Group is one of Europe’s leading cannabis companies and part of Organigram Global. The group develops and brings together its own brands and businesses across medical cannabis, research on cannabinoid-based finished medicinal products, cosmetics, wellbeing and lifestyle. Sanity Group also takes part in scientific pilot projects on adult-use cannabis in Switzerland.

about us

Our Brands

An overview of our brands in medical cannabis, scientific pilot projects on adult-use cannabis and CBD products.

ZOIKS aims to improve patient care with high-quality medicinal cannabis through particularly affordable medicines.

avaay Medical supplies patients with high-quality cannabis medicines - for a individualized therapy with natural products.

Vayamed is a fully licensed pharmaceutical company that distributes medical cannabis medicines to pharmacies and clinical facilities - focusing on the supply to patients with statutory health insurance.

Grashaus Projects is an official scientific pilot project for adult-use cannabis in Switzerland, investigating the effects of the legal sale of THC-containing products on the consumption behaviour of study participants.

vaay positions itself as the "wellbeing brand" of Sanity Group, focusing on CBD products in the fields of cosmetics, dietary supplements, and lifestyle.

Our Brands

Status Quo of Our Industry

2 Personen in Schutzanzügen und Haarnetzen stehen in einem Gewächshaus zwischen hohen Pflanzen

Cannabis Knowledge

Cannabis is gaining legal status and social acceptance worldwide, for medical purposes as well as for recreational use. Europe is taking its own path, with regulatory models that put medical care, scientific evidence and high quality standards at the centre.

With around 740 million people, the continent offers significant growth potential and is a key part of our global strategy to connect medical cannabis care across markets and continents.

Cannabis Knowledge

Originating in Europe's largest cannabis market – Germany – Sanity Group has specialised in the complex regulations and requirements surrounding cannabis in order to further explore the plant's potential and make it accessible in a controlled manner.

Our Purpose